Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, Wei W, Lemmens VEPP, Soerjomataram I. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108–18.

Article  PubMed  Google Scholar 

McGlynn KA, Petrick JL, El-Serag HB: Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021; 73 Suppl 1(Suppl 1)

Myers JA, Miller JS. Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol. 2021;18(2):85–100.

Article  PubMed  Google Scholar 

Björkström NK, Strunz B, Ljunggren H-G. Natural killer cells in antiviral immunity. Nat Rev Immunol. 2022;22(2):112–23.

Article  PubMed  Google Scholar 

Bernardini G, Antonangeli F, Bonanni V, Santoni A. Dysregulation of chemokine/chemokine receptor axes and NK cell tissue localization during diseases. Front Immunol. 2016;7:402.

Article  PubMed  PubMed Central  Google Scholar 

Yan X, Yao C, Fang C, Han M, Gong C, Hu D, Shen W, Wang L, Li S, Zhu S. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Int J Biol Sci. 2022;18(2):585–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Vito C, Mikulak J, Zaghi E, Pesce S, Marcenaro E, Mavilio D. NK cells to cure cancer. Semin Immunol. 2019;41:101272.

Article  PubMed  Google Scholar 

Tanaka J, Miller JS. Recent progress in and challenges in cellular therapy using NK cells for hematological malignancies. Blood Rev. 2020;44:100678.

Article  CAS  PubMed  Google Scholar 

Sedgwick AJ, Ghazanfari N, Constantinescu P, Mantamadiotis T, Barrow AD. The role of NK cells and innate lymphoid cells in brain cancer. Front Immunol. 2020;11:1549.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Da Y, Liu Y, Hu Y, Liu W, Ma J, Lu N, Zhang C, Zhang C. STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer. Oncoimmunology. 2022;11(1):2054105.

Article  PubMed  PubMed Central  Google Scholar 

Gong Z, Li Q, Shi J, Liu ET, Shultz LD, Ren G. Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells. Cell Metab. 2022;34(12):1960–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Z, You Y, Chen Q, Li G, Pan W, Yang Q, Dong J, Wu Y, Bei J-X, Pan C, et al. Extracellular vesicle-mediated communication between hepatocytes and natural killer cells promotes hepatocellular tumorigenesis. Mol Ther. 2022;30(2):606–20.

Article  CAS  PubMed  Google Scholar 

Fisicaro P, Boni C. T and NK cell-based immunotherapy in chronic viral hepatitis and hepatocellular carcinoma. Cells. 2022;11(2):180.

Article  PubMed  PubMed Central  Google Scholar 

Sun H, Huang Q, Huang M, Wen H, Lin R, Zheng M, Qu K, Li K, Wei H, Xiao W, et al. Human CD96 correlates to natural killer cell exhaustion and predicts the prognosis of human hepatocellular carcinoma. Hepatology. 2019;70(1):168–83.

Article  CAS  PubMed  Google Scholar 

Zhang P-F, Gao C, Huang X-Y, Lu J-C, Guo X-J, Shi G-M, Cai J-B, Ke A-W. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma. Mol Cancer. 2020;19(1):110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.

Article  PubMed  PubMed Central  Google Scholar 

Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.

Article  PubMed  Google Scholar 

Liu Z, Song C, Suo C, Fan H, Zhang T, Jin L, Chen X. Alcohol consumption and hepatocellular carcinoma: novel insights from a prospective cohort study and nonlinear Mendelian randomization analysis. BMC Med. 2022;20(1):413.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma J, Li J, Jin C, Yang J, Zheng C, Chen K, Xie Y, Yang Y, Bo Z, Wang J, et al. Association of gut microbiome and primary liver cancer: a two-sample Mendelian randomization and case-control study. Liver Int. 2023;43(1):221–33.

Article  PubMed  Google Scholar 

Yang C, Wu X, Chen S, Xiang B. Association between telomere length and hepatocellular carcinoma risk: a Mendelian randomization study. Cancer Med. 2023;12(8):9937–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Cheng J, Zhong C, Xia Q, Li Y, Chen P, Fan X, Mao Q, Lin H, Hong D. ESR1 regulates the obesity- and metabolism-differential gene MMAA to inhibit the occurrence and development of hepatocellular carcinoma. Front Oncol. 2022;12:899969.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kwiatkowska M, Jarosiewicz P, Michalowicz J, Koter-Michalak M, Huras B, Bukowska B. The impact of glyphosate, its metabolites and impurities on viability, ATP level and morphological changes in human peripheral blood mononuclear cells. PLoS ONE. 2016;11(6):e0156946.

Article  PubMed  PubMed Central  Google Scholar 

Webster GA, Bowles MJ, Karim MS, Wood RF, Pockley AG. Flow cytometric analysis of peripheral blood lymphocyte subset light scatter characteristics as a means of monitoring the development of rat small bowel allograft rejection. Clin Exp Immunol. 1995;100(3):536–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao Z, Wu Y, Li Q, Li Y, Wu J. A causal relationship between childhood obesity and risk of osteoarthritis: results from a two-sample Mendelian randomization analysis. Ann Med. 2022;54(1):1636–45.

Article  PubMed  PubMed Central  Google Scholar 

Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.

Article  PubMed  PubMed Central  Google Scholar 

Cho Y, Haycock PC, Sanderson E, Gaunt TR, Zheng J, Morris AP, Davey Smith G, Hemani G. Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework. Nat Commun. 2020;11(1):1010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta V, Walia GK, Sachdeva MP. “Mendelian randomization”: an approach for exploring causal relations in epidemiology. Public Health. 2017;145:113–9.

Article  CAS  PubMed  Google Scholar 

Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.

Article  PubMed  PubMed Central  Google Scholar 

Cai J, Li X, Wu S, Tian Y, Zhang Y, Wei Z, Jin Z, Li X, Chen X, Chen WX. Assessing the causal association between human blood metabolites and the risk of epilepsy. J Transl Med. 2022;20(1):437.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10(4):486–96.

Article  PubMed  PubMed Central  Google Scholar 

Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081.

Article  PubMed  PubMed Central  Google Scholar 

Margalit M, Shibolet O, Klein A, Elinav E, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Int J Cancer. 2005;115(3):443–9.

Article  CAS  PubMed  Google Scholar 

Wang H, Yin S. Natural killer T cells in liver injury, inflammation and cancer. Expert Rev Gastroenterol Hepatol. 2015;9(8):1077–85.

Article  CAS  PubMed  Google Scholar 

Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells. Scand J Immunol. 2007;65(2):126–38.

Article  CAS  PubMed  Google Scholar 

Hu J, Wang E, Liu L, Wang Q, Xia D, Bai W, Tie J, Li X, Yuan J, Yang S, et al. Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells. Invest New Drugs. 2020;38(5):1247–56.